POSTED
AT 9:13 PM
BY admin

Dr George Syrmalis, Founder & CEO of The IQ Group Global in CEO Magazine

Dr George Syrmalis, Founder & CEO of The IQ Group Global in CEO Magazine. An oncology drug that introduces a new therapeutic class and a glucose biosensor that could change the way diabetes is managed forever.